☆ 4.6 Letter

Pediatric high-grade glioma MYCN is frequently associated with Li-Fraumeni syndrome

ACTA NEUROPATHOLOGICA COMMUNICATIONS (2023)

Journal

ACTA NEUROPATHOLOGICA COMMUNICATIONS

Volume 11, Issue 1, Pages -

Publisher

BMC

DOI: 10.1186/s40478-022-01490-w

Keywords

-

Categories

Neurosciences

Ask authors/readers for more resources

Protocol

Community support

Reagent

Community support

Authors

I am an author on this paper

Click your name to claim this paper and add it to your profile.

Reviews

Primary Rating

4.6

Not enough ratings

Secondary Ratings

Novelty

-

Significance

-

Scientific rigor

-

Rate this paper

Recommended

Article Oncology

Clinical outcome of pediatric medulloblastoma patients with Li-Fraumeni syndrome

Anna S. Kolodziejczak, Lea Guerrini-Rousseau, Julien Masliah Planchon, Jonas Ecker, Florian Selt, Martin Mynarek, Denise Obrecht, Martin Sill, Robert J. Autry, Eric Stutheit-Zhao, Steffen Hirsch, Elsa Amouyal, Christelle Dufour, Olivier Ayrault, Jacob Torrejon, Sebastian M. Waszak, Vijay Ramaswamy, Virve Pentikainen, Haci Ahmet Demir, Steven C. Clifford, Ed C. Schwalbe, Luca Massimi, Matija Snuderl, Kristyn Galbraith, Matthias A. Karajannis, Katherine Hill, Bryan K. Li, Mike Walsh, Christine L. White, Shelagh Redmond, Loizou Loizos, Marcus Jakob, Uwe R. Kordes, Irene Schmid, Julia Hauer, Claudia Blattmann, Maria Filippidou, Gianluca Piccolo, Wolfram Scheurlen, Ahmed Farrag, Kerstin Grund, Christian Sutter, Torsten Pietsch, Stephan Frank, Denis M. Schewe, David Malkin, Myriam Ben-Arush, Astrid Sehested, Tai-Tong Wong, Kuo-Sheng Wu, Yen-Lin Liu, Fernando Carceller, Sabine Mueller, Schuyler Stoller, Michael D. Taylor, Uri Tabori, Eric Bouffet, Marcel Kool, Felix Sahm, Andreas von Deimling, Andrey Korshunov, Katja von Hoff, Christian P. Kratz, Dominik Sturm, David T. W. Jones, Stefan Rutkowski, Cornelis M. van Tilburg, Olaf Witt, Gaelle Bougeard, Kristian W. Pajtler, Stefan M. Pfister, Franck Bourdeaut, Till Milde

Summary: This retrospective cohort study investigated medulloblastoma in Li-Fraumeni syndrome (LFS) patients and found poor prognosis. The results showed that patients who received radiotherapy and chemotherapy had better clinical outcomes, while chemotherapy intensity did not affect their prognosis.

NEURO-ONCOLOGY (2023)

Add to Collection

Article Oncology

WDR82-Mediated H3K4me3 Is Associated with Tumor Proliferation and Therapeutic Efficacy in Pediatric High-Grade Gliomas

Nitin Wadhwani, Sonali Nayak, Yufen Wang, Rintaro Hashizume, Chunfa Jie, Barbara Mania-Farnell, Charles David James, Guifa Xi, Tadanori Tomita

Summary: Pediatric high-grade gliomas (pHGGs) are incurable brain tumors, but a new potential therapeutic target, WDR82-mediated H3K4me3, has been identified. Downregulation of WDR82 reduces H3K4me3 levels, leading to decreased expression of genes associated with tumor stem cell features, cell proliferation, the cell cycle, and DNA damage repair, thereby increasing the sensitivity to chemotherapy.

CANCERS (2023)

Add to Collection

Article Neurosciences

Defining tumor-associated vascular heterogeneity in pediatric high-grade and diffuse midline gliomas

Xin Wei, Michael H. Meel, Marjolein Breur, Marianna Bugiani, Esther Hulleman, Timothy N. Phoenix

Summary: The study analyzed the neurovascular unit of pediatric high-grade glioma and diffuse midline glioma, revealing tumor-associated vascular differences between the two subtypes. The research showed that DMG models maintain a more normal vascular architecture compared to pHGG models, highlighting vascular heterogeneity and differences in response to alterations in developmental BBB signals.

ACTA NEUROPATHOLOGICA COMMUNICATIONS (2021)

Add to Collection

Article Biochemistry & Molecular Biology

Clusterin Is a Prognostic Biomarker of Lower-Grade Gliomas and Is Associated with Immune Cell Infiltration

Xiaoyue Ren, Chao Chang, Teng Qi, Pengyu Yang, Yuanbo Wang, Xiaorui Zhou, Feng Guan, Xiang Li

Summary: Dysregulation of clusterin (CLU) has been found in various cancers, including gliomas. High CLU expression is associated with worse prognosis and higher risk in low-grade glioma patients. CLU is involved in immune status and has correlations with immune cells and immune-related pathways in gliomas. These findings suggest that CLU may serve as a potential biomarker or target in glioma immunotherapy.

INTERNATIONAL JOURNAL OF MOLECULAR SCIENCES (2023)

Add to Collection

Article Oncology

Breast Cancer Phenotype Associated With Li-Fraumeni Syndrome: A Brazilian Cohort Enriched by TP53 p.R337H Carriers

Renata Lazari Sandoval, Natalia Polidorio, Ana Carolina Rathsam Leite, Mariana Cartaxo, Janina Pontes Pisani, Carla Vanessa Quirino, Loureno Cezana, Natalya Goncalves Pereira, Allan Andresson Lima Pereira, Benedito Mauro Rossi, Maria Isabel Achatz

Summary: The phenotype of breast cancer in Brazilian female carriers of Li-Fraumeni syndrome, particularly those with the TP53 p.R337H variant, is similar to that of carriers with other TP53 pathogenic variants. The age at onset of the disease is older than the general population but still relatively young compared to other breast cancer cases.

FRONTIERS IN ONCOLOGY (2022)

Add to Collection

Article Otorhinolaryngology

Pediatric Head and Neck Tumors Associated with Li-Fraumeni Syndrome

Kenny D. Rodriguez, Kami Wolfe Schneider, Alexandra Suttman, Timothy Garrington, Tennyson Jellins, Kaitlyn Tholen, Christian R. Francom, Brian W. Herrmann

Summary: This study examined head and neck manifestations of Li-Fraumeni syndrome in children over a 20-year period, revealing a high potential for head and neck involvement in LFS patients, which has not been previously described in the literature. Otolaryngological care should be included in the multidisciplinary care team for these patients.

ANNALS OF OTOLOGY RHINOLOGY AND LARYNGOLOGY (2022)

Add to Collection

Review Oncology

Li-Fraumeni Syndrome: Mutation of TP53 Is a Biomarker of Hereditary Predisposition to Tumor: New Insights and Advances in the Treatment

Valentina Rocca, Giovanni Blandino, Lucia D'Antona, Rodolfo Iuliano, Silvia Di Agostino

Summary: Li-Fraumeni Syndrome (LFS) is a rare familial tumor predisposition syndrome caused by mutations in the TP53 gene. Patients with LFS are at risk of developing various types of tumors. This review explores the novel mechanisms of tumor onset in LFS and discusses potential treatment approaches.

CANCERS (2022)

Add to Collection

Article Medicine, General & Internal

ABCB1 Is Frequently Methylated in Higher-Grade Gliomas and May Serve as a Diagnostic Biomarker of More Aggressive Tumors

Aleksandra Majchrzak-Celinska, Arvinder Sidhu, Izabela Miechowicz, Witold Nowak, Anna-Maria Barciszewska

Summary: ABCB1 methylation may serve as a potential diagnostic or prognostic biomarker for glioma patients.

JOURNAL OF CLINICAL MEDICINE (2022)

Add to Collection

Letter Oncology

Genotype-phenotype associations within the Li-Fraumeni spectrum: a report from the German Registry

Judith Penkert, Farina J. Struewe, Christina M. Dutzmann, Beate B. Doergeloh, Emilie Montellier, Claire Freycon, Myriam Keymling, Heinz-Peter Schlemmer, Birte Saenger, Beatrice Hoffmann, Tanja Gerasimov, Claudia Blattmann, Sebastian Fetscher, Michael Fruhwald, Simone Hettmer, Uwe Kordes, Vita Ridola, Sabine Kroiss Benninger, Angela Mastronuzzi, Sarah Schott, Juliane Nees, Aram Prokop, Antje Redlich, Markus G. Seidel, Stefanie Zimmermann, Kristian W. Pajtler, Stefan M. Pfister, Pierre Hainaut, Christian P. Kratz

Summary: Li-Fraumeni syndrome (LFS) is a cancer predisposition syndrome caused by pathogenic TP53 variants, with high risk of developing cancer. The study found that the occurrence of NULL variants were significantly higher in LFS families compared to attenuated LFS families, and there are genotype-phenotype correlations in different types of pathogenic variants and cancer types.

JOURNAL OF HEMATOLOGY & ONCOLOGY (2022)

Add to Collection

Article Biochemistry & Molecular Biology

TP53 Pathogenic Variants in Early-Onset Breast Cancer Patients Fulfilling Hereditary Breast and Ovary Cancer and Li-Fraumeni-like Syndromes

Paula Francinete Faustino da Silva, Rebeca Mota Goveia, Thais Bomfim Teixeira, Bruno Faulin Gamba, Aliny Pereira de Lima, Silvia Regina Rogatto, Elisangela de Paula Silveira-Lacerda

Summary: TP53 gene mutations are associated with breast cancer. A study of 83 breast cancer patients in the Midwest region of Brazil found that 4 patients had pathogenic variants in the TP53 gene, highlighting the importance of genetic testing in this group.

BIOMOLECULES (2022)

Add to Collection

Review Oncology

Radiosensitization in Pediatric High-Grade Glioma: Targets, Resistance and Developments

Dennis S. Metselaar, Aimee du Chatinier, Iris Stuiver, Gertjan J. L. Kaspers, Esther Hulleman

Summary: Pediatric high-grade gliomas are fatal brain tumors in children, characterized by mutations in histone 3 genes and therapy-resistant stem cell-like phenotype. Standard treatments like surgery and radiation therapy offer limited success, but new opportunities lie in radiosensitizers for improved outcomes.

FRONTIERS IN ONCOLOGY (2021)

Add to Collection

Review Immunology

Pediatric versus adult high grade glioma: Immunotherapeutic and genomic considerations

Payal Aggarwal, Wen Luo, Katherine C. C. Pehlivan, Hai Hoang, Prajwal Rajappa, Timothy P. P. Cripe, Kevin A. A. Cassady, Dean A. A. Lee, Mitchell S. S. Cairo

Summary: This article examines the differences and similarities between high grade gliomas in adults and children, including epidemiology, etiology, pathogenesis, and treatment approaches. Although there are differences in clinical presentation, molecular biology background, and response to chemotherapy, both types of gliomas respond to immunotherapy.

FRONTIERS IN IMMUNOLOGY (2022)

Add to Collection

Article Radiology, Nuclear Medicine & Medical Imaging

Increased confidence of radiomics facilitating pretherapeutic differentiation of BRAF-altered pediatric low-grade glioma

Kareem Kudus, Matthias W. Wagner, Khashayar Namdar, Liana Nobre, Eric Bouffet, Uri Tabori, Cynthia Hawkins, Kristen W. Yeom, Birgit B. Ertl-Wagner, Farzad Khalvati

Summary: We established a nomogram to predict BRAF status non-invasively in pediatric low-grade glioma (pLGG) patients, using clinical and radiomic factors. Additionally, we assessed an advanced thresholding method to provide high-confidence predictions. Radiomic features were found to provide additional predictive information beyond tumor location.

EUROPEAN RADIOLOGY (2023)

Add to Collection

Article Genetics & Heredity

High Expression of PLAGL2 is Associated With Poor Prognosis in High-Grade Glioma

Gang Wang, Wei Du, Lingyi Che, Xianzheng Gao, Ruihua Zhao, Juan Duan, Zhuoyu Gu, Qian Ma

Summary: PLAGL2 is implicated in the development and progression of various malignancies, including glioblastoma, with dysregulated expression commonly observed. Its overexpression in high-grade glioma (HGG) is associated with poor prognosis and potential therapeutic target, making it an independent prognostic biomarker in HGG patients.

FRONTIERS IN GENETICS (2022)

Add to Collection

Article Neurosciences

CIA-II is associated with lower-grade glioma survival and cell proliferation

Feng Xiao, Hong Zhu, Yun Guo, Zhe Zhang, Gufeng Sun, Yao Xiao, Guowen Hu, Kai Huang, Hua Guo

Summary: This study found that CIA-II is highly expressed in various tumors, including lower-grade glioma (LGG), and higher CIA-II expression in LGG patients is associated with worse prognosis. Moreover, CIA-II expression is closely related to immune cell infiltration, gene mutations, and chemotherapeutics in LGG. In vitro studies also revealed that CIA-II is strongly associated with cell proliferation in LGG. Therefore, CIA-II may serve as an independent prognostic factor and a potential therapeutic target in LGG.

CNS NEUROSCIENCE & THERAPEUTICS (2023)

Add to Collection

Article Clinical Neurology

High Prevalence of Developmental Venous Anomaly in Diffuse Intrinsic Pontine Gliomas: A Pediatric Control Study

Alexandre Roux, Nathalie Boddaert, Jacques Grill, David Castel, Marc Zanello, Gilles Zah-Bi, Fabrice Chretien, Etienne Lefevre, Volodia Dangouloff Ros, Michel Zerah, Stephanie Puget, Johan Pallud, Pascale Varlet

NEUROSURGERY (2020)

Add to Collection

Article Clinical Neurology

The histomolecular criteria established for adult anaplastic pilocytic astrocytoma are not applicable to the pediatric population

Albane Gareton, Arnault Tauziede-Espariat, Volodia Dangouloff-Ros, Alexandre Roux, Raphael Saffroy, David Castel, Thomas Kergrohen, Frederic Fina, Dominique Figarella-Branger, Melanie Pages, Franck Bourdeaut, Francois Doz, Stephanie Puget, Christelle Dufour, Emmanuele Lechapt, Fabrice Chretien, Jacques Grill, Pascale Varlet

ACTA NEUROPATHOLOGICA (2020)

Add to Collection

Article Biochemical Research Methods

Rapid and Sensitive Drug Quantification in Tissue Sections Using Matrix Assisted Laser Desorption Ionization-Ion Mobility-Mass Spectrometry Profiling

Margaux Fresnais, Alexander Muck, Marius Majewsky, Britta Statz, Sonja Krausert, Julia Benzel, David Castel, Ludivine Le Dret, Stefan Pfister, Walter E. Haefeli, Jurgen Burhenne, Remi Longuespee

JOURNAL OF THE AMERICAN SOCIETY FOR MASS SPECTROMETRY (2020)

Add to Collection

Article Clinical Neurology

Histone H3 wild-type DIPG/DMG overexpressing EZHIP extend the spectrum diffuse midline gliomas with PRC2 inhibition beyond H3-K27M mutation

David Castel, Thomas Kergrohen, Arnault Tauziede-Espariat, Alan Mackay, Samia Ghermaoui, Emmanuele Lechapt, Stefan M. Pfister, Christof M. Kramm, Nathalie Boddaert, Thomas Blauwblomme, Stephanie Puget, Kevin Beccaria, Chris Jones, David T. W. Jones, Pascale Varlet, Jacques Grill, Marie-Anne Debily

ACTA NEUROPATHOLOGICA (2020)

Add to Collection

Letter Neurosciences

The pediatric supratentorial MYCN-amplified high-grade gliomas methylation class presents the same radiological, histopathological and molecular features as their pontine counterparts

A. Tauziede-Espariat, M-A Debily, D. Castel, J. Grill, S. Puget, A. Roux, R. Saffroy, M. Pages, A. Gareton, F. Chretien, E. Lechapt, V. Dangouloff-Ros, N. Boddaert, P. Varlet

ACTA NEUROPATHOLOGICA COMMUNICATIONS (2020)

Add to Collection

Article Radiology, Nuclear Medicine & Medical Imaging

Radiogenomics of diffuse intrinsic pontine gliomas (DIPGs): correlation of histological and biological characteristics with multimodal MRI features

Raphael Calmon, Volodia Dangouloff-Ros, Pascale Varlet, Christophe Deroulers, Cathy Philippe, Marie-Anne Debily, David Castel, Kevin Beccaria, Thomas Blauwblomme, David Grevent, Raphael Levy, Charles-Joris Roux, Yvonne Purcell, Ana Saitovitch, Monica Zilbovicius, Christelle Dufour, Stephanie Puget, Jacques Grill, Nathalie Boddaert

Summary: This study analyzed the MRI and histopathological features of 27 children with DIPG H3K27M mutant tumors, revealing that H3.1K27M mutated tumors have higher ADC values and lower perfusion values compared to H3.3K27M ones, possibly due to gated channel activity-related gene expression.

EUROPEAN RADIOLOGY (2021)

Add to Collection

Article Oncology

A DNA Repair and Cell Cycle Gene Expression Signature in Pediatric High-Grade Gliomas: Prognostic and Therapeutic Value

Natacha Entz-Werle, Laetitia Poidevin, Petr V. Nazarov, Olivier Poch, Benoit Lhermitte, Marie Pierre Chenard, Helene Burckel, Eric Guerin, Quentin Fuchs, David Castel, Georges Noel, Laurence Choulier, Monique Dontenwill, Eric Van Dyck

Summary: Pediatric high-grade gliomas (pHGGs) are incurable brain tumors that exhibit resistance to standard therapies. This study investigated the expression of DNA repair and cell cycle genes in pHGGs to propose a novel classification based on therapeutic vulnerabilities. Several potential new diagnostic markers were identified among the DNA repair factors studied.

CANCERS (2021)

Add to Collection

Letter Clinical Neurology

Deciphering the genetic and epigenetic landscape of pediatric bithalamic tumors

Arnault Tauziede-Espariat, Marie-Anne Debily, David Castel, Jacques Grill, Stephanie Puget, Alexandre Roux, Raphael Saffroy, Guillaume Gauchotte, Ellen Wahler, Lauren Hasty, Fabrice Chretien, Emmanuele Lechapt, Volodia Dangouloff-Ros, Nathalie Boddaert, Philipp Sievers, Pascale Varlet

Summary: Accurate diagnosis of pediatric bithalamic gliomas requires a comprehensive neuropathological review, including immunohistochemistry, genetic, and epigenetic analyses.

BRAIN PATHOLOGY (2022)

Add to Collection

Article Neurosciences

The dural angioleiomyoma harbors frequent GJA4 mutation and a distinct DNA methylation profile

Arnault Tauziede-Espariat, Thibaut Pierre, Michel Wassef, David Castel, Florence Riant, Jacques Grill, Alexandre Roux, Johan Pallud, Edouard Dezamis, Damien Bresson, Sandro Benichi, Thomas Blauwblomme, Djallel Benzohra, Guillaume Gauchotte, Celso Pouget, Sophie Colnat-Coulbois, Karima Mokhtari, Corinne Balleyguier, Frederique Larousserie, Volodia Dangouloff-Ros, Nathalie Boddaert, Marie-Anne Debily, Lauren Hasty, Marc Polivka, Homa Adle-Biassette, Alice Metais, Emmanuele Lechapt, Fabrice Chretien, Felix Sahm, Philipp Sievers, Pascale Varlet

Summary: This study identified three unclassified vascular lesions in the central nervous system (CNS) that shared radiological and histopathological features similar to a subtype of angioleiomyomas in soft tissue. Molecular analysis revealed a common GJA4 mutation in these lesions, which was also found in soft tissue angioleiomyomas. Further analysis showed that these CNS lesions formed a distinct epigenetic group separate from other vascular tumors and soft tissue angioleiomyomas.

ACTA NEUROPATHOLOGICA COMMUNICATIONS (2022)

Add to Collection

Article Clinical Neurology

The genomic landscape of dysembryoplastic neuroepithelial tumours and a comprehensive analysis of recurrent cases

Melanie Pages, Marie-Anne Debily, Frederic Fina, David T. W. Jones, Raphael Saffroy, David Castel, Thomas Blauwblomme, Alice Metais, Marie Bourgeois, Emmanuele Lechapt-Zalcman, Arnault TauziedeEspariat, Felipe Andreiuolo, Fabrice Chretien, Jacques Grill, Nathalie Boddaert, Dominique Figarella-Branger, Rameen Beroukhim, Pascale Varlet

Summary: Dysembryoplastic neuroepithelial tumour (DNT) is a challenging glioneuronal tumour with diverse histological features. The study used comprehensive analysis techniques to characterize 82 DNTs, revealing differences between specific and non-specific/diffuse DNTs, as well as identifying additional genomic alterations in a subset of DNTs.

NEUROPATHOLOGY AND APPLIED NEUROBIOLOGY (2022)

Add to Collection

Letter Neurosciences

Disseminated diffuse midline gliomas, H3K27-altered mimicking diffuse leptomeningeal glioneuronal tumors: a diagnostical challenge!

Arnault Tauziede-Espariat, Aurore Siegfried, Emmanuelle Uro-Coste, Yvan Nicaise, David Castel, Annick Sevely, Marion Gambart, Sergio Boetto, Lauren Hasty, Alice Metais, Fabrice Chretien, Joseph Benzakoun, Stephanie Puget, Jacques Grill, Volodia Dangouloff-Ros, Nathalie Boddaert, Azadeh Ebrahimi, Pascale Varlet

ACTA NEUROPATHOLOGICA COMMUNICATIONS (2022)

Add to Collection

Article Neurosciences

Posterior fossa ependymoma H3 K27-mutant: an integrated radiological and histomolecular tumor analysis

Cassandra Mariet, David Castel, Jacques Grill, Raphael Saffroy, Volodia Dangouloff-Ros, Nathalie Boddaert, Francisco Llamas-Guttierrez, Celine Chappe, Stephanie Puget, Lauren Hasty, Fabrice Chretien, Alice Metais, Pascale Varlet, Arnault Tauziede-Espariat

Summary: This study retrospectively investigated 9 cases of pediatric H3 K27M-mutant EPN_PFA and found that 7 tumors clustered with EPN_PFA, while one was reclassified as DMG. H3 K27M-mutant EPN_PFA cases were older and showed similarities in radiology and histopathology with EZHIP-overexpressing EPN_PFA. Sequencing analysis revealed K27M mutations in HIST1H3B, HIST1H3C, H3F3A, and HIST1H3D. Overall survival rates were similar between EZHIP-overexpressing and H3 K27M-mutant EPN_PFA.

ACTA NEUROPATHOLOGICA COMMUNICATIONS (2022)

Add to Collection

Letter Neurosciences

NF2 and ZFTA evaluation in the diagnostic algorithm of pediatric posterior fossa ependymoma with H3K27ME3 retained expression

Arnault Tauziede-Espariat, Yassine Ajlil, Marie-Anne Debily, David Castel, Jacques Grill, Stephanie Puget, Lauren Hasty, Fabrice Chretien, Alice Metais, Volodia Dangouloff-Ros, Nathalie Boddaert, Pascale Varlet

ACTA NEUROPATHOLOGICA COMMUNICATIONS (2023)

Add to Collection

Article Oncology

A subset of pediatric-type thalamic gliomas share a distinct DNA methylation profile, H3K27me3 loss and frequent alteration of EGFR

Philipp Sievers, Martin Sill, Daniel Schrimpf, Damian Stichel, David E. Reuss, Dominik Sturm, Jurgen Hench, Stephan Frank, Lenka Krskova, Ales Vicha, Michal Zapotocky, Brigitte Bison, David Castel, Jacques Grill, Marie-Anne Debily, Patrick N. Harter, Matija Snuderl, Christof M. Kramm, Guido Reifenberger, Andrey Korshunov, Nada Jabado, Pieter Wesseling, Wolfgang Wick, David A. Solomon, Arie Perry, Thomas S. Jacques, Chris Jones, Olaf Witt, Stefan M. Pfister, Andreas von Deimling, David T. W. Jones, Felix Sahm

Summary: A study identified a specific molecular class of pediatric-type malignant gliomas with EGFR amplifications or mutations, as well as H3.1 or H3.3 K27M mutations, all showing loss of H3K27me3 staining. While some tumors exhibited a bithalamic growth pattern, a significant proportion occurred in other locations.

NEURO-ONCOLOGY (2021)

Add to Collection

No Data Available

© Peeref 2019-2024. All rights reserved.